These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 21428840)

  • 1. Label-free screening assays: a strategy for finding better drug candidates.
    Lunn CA
    Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening Europe 2010: an update about the latest technologies and applications in high-throughput screening.
    Merten CA
    Expert Rev Mol Diagn; 2010 Jul; 10(5):559-63. PubMed ID: 20629504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward high-throughput drug screening on a chip-based parallel affinity separation platform.
    Ohlson S; Duong-Thi MD; Bergström M; Fex T; Hansson L; Pedersen L; Guazotti S; Isaksson R
    J Sep Sci; 2010 Sep; 33(17-18):2575-81. PubMed ID: 20730836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening.
    Zhang JH; Roddy TP; Ho PI; Horvath CR; Vickers C; Stout S; Hubbard B; Wang YK; Hill WA; Bojanic D
    J Biomol Screen; 2010 Jul; 15(6):695-702. PubMed ID: 20484097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native MS: an 'ESI' way to support structure- and fragment-based drug discovery.
    Vivat Hannah V; Atmanene C; Zeyer D; Van Dorsselaer A; Sanglier-Cianférani S
    Future Med Chem; 2010 Jan; 2(1):35-50. PubMed ID: 21426045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A robust high-throughput sandwich cell-based drug screening platform.
    Zhang S; Tong W; Zheng B; Susanto TA; Xia L; Zhang C; Ananthanarayanan A; Tuo X; Sakban RB; Jia R; Iliescu C; Chai KH; McMillian M; Shen S; Leo H; Yu H
    Biomaterials; 2011 Feb; 32(4):1229-41. PubMed ID: 20971505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a rapid and integrated analysis system (RIAS) as a high-throughput processing tool for in vitro ADME samples by liquid chromatography/tandem mass spectrometry.
    Luippold AH; Arnhold T; Jörg W; Krüger B; Süssmuth RD
    J Biomol Screen; 2011 Mar; 16(3):370-7. PubMed ID: 21335598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High content screening: seeing is believing.
    Zanella F; Lorens JB; Link W
    Trends Biotechnol; 2010 May; 28(5):237-45. PubMed ID: 20346526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput metabolic stability studies in drug discovery by orthogonal acceleration time-of-flight (OATOF) with analogue-to-digital signal capture (ADC).
    Temesi DG; Martin S; Smith R; Jones C; Middleton B
    Rapid Commun Mass Spectrom; 2010 Jun; 24(12):1730-6. PubMed ID: 20499316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating surface plasmon resonance biosensor-based interaction kinetic analyses into the lead discovery and optimization process.
    Danielson UH
    Future Med Chem; 2009 Nov; 1(8):1399-414. PubMed ID: 21426056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of LC-high-resolution MS with 'intelligent' data mining tools for screening reactive drug metabolites.
    Ma S; Chowdhury SK
    Bioanalysis; 2012 Mar; 4(5):501-10. PubMed ID: 22409549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supercritical fluid chromatography in research laboratories: design, development and implementation of an efficient generic screening for exploiting this technique in the achiral environment.
    de la Puente ML; López Soto-Yarritu P; Burnett J
    J Chromatogr A; 2011 Nov; 1218(47):8551-60. PubMed ID: 22018480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of fluorescence imaging-based assay for screening cardioprotective compounds from medicinal plants.
    Wang Y; Zhao X; Gao X; Nie X; Yang Y; Fan X
    Anal Chim Acta; 2011 Sep; 702(1):87-94. PubMed ID: 21819864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-free imaging and temporal signature in phenotypic cellular assays: a new approach to high-content screening.
    Martin J
    Curr Protoc Pharmacol; 2010 Sep; Chapter 9():Unit 9.13. PubMed ID: 22294376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.
    Heeres JT; Hergenrother PJ
    Chem Soc Rev; 2011 Aug; 40(8):4398-410. PubMed ID: 21140010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The zebrafish: a powerful platform for in vivo, HTS drug discovery.
    Delvecchio C; Tiefenbach J; Krause HM
    Assay Drug Dev Technol; 2011 Aug; 9(4):354-61. PubMed ID: 21309713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay.
    Plant M; Dineen T; Cheng A; Long AM; Chen H; Morgenstern KA
    Anal Biochem; 2011 Dec; 419(2):217-27. PubMed ID: 21855527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.